neuroregeneration gene therapy (AMT)

N/A

Report date: 2025/03/20 20:00:06

Base Information

Drug Nameneuroregeneration gene therapy (AMT)

Drug Alias Nameneuroregeneration gene therapy (Amsterdam Molecular Therapeutics)spinal cord injury gene therapy (AMT)spinal cord injury gene therapy (Amsterdam Molecular Therapeutics)

ClassificationCell and gene therapy > Cell therapyCell and gene therapy > Gene therapy > Viral vector-based gene therapy > Adeno-associated virus vector

Mechanisms of ActionUpdating

TargetsUpdating

Therapy Area/IndicationsTrauma, Nervous SystemSpinal Cord Injuries

Global Approved IndicationsN/A

Approved Indications in ChinaN/A

Original Approved Country/TerritoryN/A

Original Approved DateN/A

Country/TerritoryNetherlands

CombinationsNo

Global Highest StatusPending (Preclinical)

Highest Status in ChinaN/A

Originator CompaniesAmsterdam Molecular Therapeutics

China Registration ClassN/A

Develop Information

Active CompaniesN/A

Inactive CompaniesAmsterdam Molecular Therapeutics

Active IndicationsN/A

Inactive IndicationsTrauma, Nervous SystemSpinal Cord Injuries

Other Information

ATC CodeN/A